O'Reilly Automotive, Inc. · ORLY · FY2026 Q2 · Calendar Q3 2026
O'Reilly raises 2026 outlook as Q2 demand stays solid
O'Reilly's Q2 analysis supports a constructive operating trajectory: demand remained solid, management raised both EPS and comparable-store-sales guidance, and the company continues to invest in stores, distribution and inventory. The main test is whether growth can persist as same-SKU inflation moderates and consumers face higher fuel costs and price sensitivity.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about ORLY FY2026 Q2
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Compared with the prior quarter, management raised comparable-store-sales guidance to 4%-6% from 3%-5% and lifted EPS guidance to $3.20-$3.30. The current analysis also highlights a 1%-2% second-half same-SKU inflation expectation, unchanged gross-margin guidance, and a trimmed SG&A per-store growth outlook of 3.5%-4%.
Guidance delta
Management raised full-year EPS guidance to $3.20-$3.30 and comparable store-sales guidance to 4%-6%, while keeping gross-margin guidance unchanged.
Key takeaways
- Quarterly sales rose $367 million, supported by 6% comparable-store growth and a $100 million non-comp contribution.
- EPS guidance increased to $3.20-$3.30 on strong first-half performance and share repurchases.
- Full-year comparable-store-sales guidance rose to 4%-6%, from 3%-5%.
- Gross margin held at 51.4%, while SG&A per-store growth guidance was trimmed to 3.5%-4%.
- Same-SKU inflation is expected to moderate to 1%-2% in the second half of 2026.
Management priorities
- Open 225-235 net new stores in 2026 across the U.S., Canada, and Mexico.
- Invest $1.3-$1.4 billion in capex, including distribution capacity and the Atlanta distribution center.
- Increase inventory per store by 5% by year-end.
- Prioritize share repurchases as excess cash is generated.
- Pursue selective tuck-in acquisitions that fit the O'Reilly model.
Follow ORLY with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 30, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 29, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 26, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 20, 2026 |
| DA Davidson | Buy | Buy | Maintain | Sep 18, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 3, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 31, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Mizuho | Outperform | Outperform | Maintain | May 8, 2026 |
| Truist Securities | Buy | Buy | Maintain | Feb 6, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 6, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 27, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 24, 2025 |
| Guggenheim | Buy | Buy | Maintain | Jul 25, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 25, 2025 |
| Wedbush | Neutral | Neutral | Maintain | Feb 6, 2025 |
| B of A Securities | Buy | Buy | Maintain | Aug 22, 2024 |
| Stephens & Co. | Overweight | Overweight | Maintain | Dec 19, 2023 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 6, 2023 |
| Roth MKM | Buy | Buy | Maintain | May 12, 2023 |
| MKM Partners | Buy | Buy | Maintain | Jun 23, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Jul 27, 2021 |
| Nomura Instinet | Neutral | Neutral | Maintain | May 20, 2020 |
| Nomura | Neutral | Neutral | Maintain | May 20, 2020 |
| Atlantic Equities | Underweight | Neutral | Downgrade | Jan 23, 2020 |
| Credit Suisse | Neutral | Neutral | Maintain | Oct 25, 2019 |
| Northcoast Research | Neutral | Buy | Downgrade | Jun 27, 2019 |
| Jefferies | Buy | Buy | Maintain | Oct 26, 2018 |
| Bank of America | Buy | Buy | Maintain | Sep 17, 2018 |
| MoffettNathanson | Neutral | Buy | Downgrade | Jun 25, 2018 |
| Moffett Nathanson | Neutral | Buy | Downgrade | Jun 25, 2018 |
| Baird | Neutral | Neutral | Maintain | Feb 9, 2018 |
| Susquehanna | Neutral | Positive | Downgrade | Jun 20, 2017 |
| Deutsche Bank | Hold | Buy | Downgrade | Apr 25, 2017 |
| Cleveland Research | Neutral | Buy | Downgrade | Apr 3, 2017 |
| BTIG Research | Buy | Buy | Maintain | Jun 1, 2016 |
| Gabelli & Co. | Buy | Buy | Maintain | Apr 15, 2016 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 12, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Jan 25, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Jan 25, 2016 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Jul 18, 2014 |
| Stifel | Hold | Buy | Downgrade | Jul 18, 2014 |
| PiperJaffray | Neutral | Overweight | Downgrade | Jan 7, 2013 |
| Piper Sandler | Neutral | Overweight | Downgrade | Jan 7, 2013 |
| Bank oferica | Buy | Buy | Maintain | Apr 26, 2012 |
| Morgan Keegan | Outperform | Outperform | Maintain | Feb 10, 2012 |
| Cabrera Capital Markets | Outperform | Outperform | Maintain | Feb 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $92.65. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Kate McShane | $104 | $88.07 | +12.3% | Oct 30, 2026 |
| Bernstein | Zhihan Ma | $94 | $86.51 | +1.5% | Sep 29, 2026 |
| Roth Capital | Scott Stember | $111 | $88.48 | +19.8% | Jul 31, 2026 |
| D.A. Davidson | Analyst unavailable | $106 | $88.47 | +14.4% | Jul 31, 2026 |
| Raymond James | Bobby Griffin | $110 | $88.86 | +18.7% | Jul 31, 2026 |
| Robert W. Baird | Analyst unavailable | $100 | $87.36 | +7.9% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $100 | $86.11 | +7.9% | Jul 24, 2026 |
| D.A. Davidson | Michael Baker | $114 | $87.72 | +23.0% | Jul 22, 2026 |
| Wolfe Research | Analyst unavailable | $98 | $85.75 | +5.8% | Jul 15, 2026 |
| Goldman Sachs | Kate McShane | $113 | $87.28 | +22.0% | Jul 13, 2026 |
| Roth Capital | Analyst unavailable | $109 | $96.83 | +17.6% | May 4, 2026 |
| Robert W. Baird | Analyst unavailable | $110 | $98.71 | +18.7% | May 1, 2026 |
| Evercore ISI | Greg Melich | $115 | $99.19 | +24.1% | May 1, 2026 |
| Raymond James | Analyst unavailable | $115 | $98.69 | +24.1% | May 1, 2026 |
| Truist Financial | Analyst unavailable | $108 | $99.4 | +16.6% | Apr 30, 2026 |
| Morgan Stanley | Simeon Gutman | $112 | $97.58 | +20.9% | Apr 30, 2026 |
| Wells Fargo | Analyst unavailable | $110 | $91.69 | +18.7% | Apr 30, 2026 |
| Morgan Stanley | Analyst unavailable | $108 | $92.96 | +16.6% | Feb 9, 2026 |
| Truist Financial | Analyst unavailable | $107 | $92.3 | +15.5% | Feb 6, 2026 |
| Robert W. Baird | Analyst unavailable | $96 | $91.94 | +3.6% | Feb 6, 2026 |
| D.A. Davidson | Michael Baker | $110 | $92.08 | +18.7% | Feb 6, 2026 |
| RBC Capital | Steven Shemesh | $109 | $92.3 | +17.6% | Feb 6, 2026 |
| UBS | Analyst unavailable | $114 | $92.08 | +23.0% | Feb 6, 2026 |
| Mizuho Securities | Analyst unavailable | $105 | $92.86 | +13.3% | Feb 6, 2026 |
| RBC Capital | Steven Shemesh | $111 | $98.85 | +19.8% | Jan 30, 2026 |
| Morgan Stanley | Analyst unavailable | $110 | $95.02 | +18.7% | Jan 15, 2026 |
| Evercore ISI | Analyst unavailable | $110 | $94.31 | +18.7% | Dec 16, 2025 |
| Robert W. Baird | Analyst unavailable | $115 | $98.61 | +24.1% | Dec 3, 2025 |
| Raymond James | Bobby Griffin | $105 | $93.83 | +13.3% | Nov 5, 2025 |
| Barclays | Seth Sigman | $91 | $95.68 | -1.8% | Oct 27, 2025 |
| Truist Financial | Scot Ciccarelli | $109 | $98.12 | +17.6% | Oct 24, 2025 |
| RBC Capital | Steven Shemesh | $110 | $98.27 | +18.7% | Oct 24, 2025 |
| Goldman Sachs | Analyst unavailable | $121 | $98.27 | +30.6% | Oct 24, 2025 |
| Morgan Stanley | Simeon Gutman | $115 | $100 | +24.1% | Oct 23, 2025 |
| Mizuho Securities | Analyst unavailable | $112 | $101.6 | +20.9% | Oct 20, 2025 |
| UBS | Michael Lasser | $120 | $103.05 | +29.5% | Oct 15, 2025 |
| Wells Fargo | Analyst unavailable | $115 | $103.05 | +24.1% | Oct 15, 2025 |
| Wolfe Research | Analyst unavailable | $121 | $104.55 | +30.6% | Sep 17, 2025 |
| UBS | Michael Lasser | $1,580 | $1,352.17 | +1605.3% | Apr 24, 2025 |
| Truist Financial | Scot Ciccarelli | $1,290 | $1,187.53 | +1292.3% | Oct 14, 2024 |
| Wells Fargo | Zachary Fadem | $1,325 | $1,187.53 | +1330.1% | Oct 14, 2024 |
| Evercore ISI | Greg Melich | $1,230 | $1,138.16 | +1227.6% | Aug 22, 2024 |
| Jefferies | Bret Jordan | $1,260 | $1,110.31 | +1260.0% | Jul 26, 2024 |
| RBC Capital | Steven Shemesh | $1,115 | $1,117.06 | +1103.5% | Jul 26, 2024 |
| Truist Financial | Scot Ciccarelli | $1,204 | $1,092.91 | +1199.5% | Jul 25, 2024 |
| Truist Financial | Scot Ciccarelli | $1,143 | $1,016.32 | +1133.7% | Jul 2, 2024 |
| CFRA | Garrett Nelson | $1,100 | $921.64 | +1087.3% | Oct 26, 2023 |
| Barclays | Analyst unavailable | $815 | $801.02 | +779.7% | Feb 8, 2023 |
| Wells Fargo | Analyst unavailable | $925 | $830.21 | +898.4% | Jan 5, 2023 |
| Citigroup | Analyst unavailable | $855 | $851.38 | +822.8% | Nov 23, 2022 |
| D.A. Davidson | Mike Baker | $740 | $637.6 | +698.7% | Jun 29, 2022 |
| Morgan Stanley | Analyst unavailable | $650 | $618.48 | +601.6% | Apr 29, 2022 |
| RBC Capital | Analyst unavailable | $806 | $623.28 | +769.9% | Apr 29, 2022 |
| Wells Fargo | Zachary Fadem | $800 | $703.6 | +763.5% | Apr 25, 2022 |
| Citigroup | Steven Zaccone | $720 | $665.67 | +677.1% | Jan 18, 2022 |
| D.A. Davidson | Michael Baker | $700 | $701.77 | +655.5% | Dec 30, 2021 |
| Oppenheimer | Brian Nagel | $800 | $672 | +763.5% | Dec 9, 2021 |
| UBS | Michael Lasser | $720 | $638.33 | +677.1% | Oct 18, 2021 |
| Goldman Sachs | Kate McShane | $638 | $607.38 | +588.6% | Jul 20, 2021 |
| Credit Suisse | Lavesh Hemnani | $496 | $548.07 | +435.3% | May 18, 2021 |
Track every rating change on ORLY the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationO'Reilly Automotive, Inc., along with its subsidiary companies, functions as a leading retail and wholesale provider of automotive aftermarket products, specialized tools, supplies, and accessories across the United States. The company's comprehensive inventory includes both new and reconditioned vehicle hard parts and essential maintenance items. This expansive selection covers critical components such as alternators, batteries, brake system parts, belts, chassis and driveline components, engine parts, fuel pumps, hoses, starters, temperature control systems, and water pumps. Additionally, they supply consumables like antifreeze, appearance products, engine additives, filters, various fluids, lighting solutions, oil, and wiper blades. Their accessory range features items like floor mats, seat covers, and specific truck enhancements. Beyond just parts, O'Reilly's outlets also stock auto body paint and related materials, a wide array of automotive tools, and specialized equipment catering to professional service providers.…
Historical context
All ORLY earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ROST Ross Stores, Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.1% | -2.8% | Ross Stores: traffic-led growth lifts FY26 EPS outlook |
| WSM Williams-Sonoma, Inc. | FY2026 Q3 · Calendar Q4 2026 | 0.0% | -15.2% | Williams-Sonoma grows sales and expands margin as guidance holds |
| BABA Alibaba Group Holding Limited | FY2027 Q2 · Calendar Q4 2026 | -29.2% | -1.3% | Alibaba’s cloud growth accelerates, while export controls temper near-term outlook |
| PDD PDD Holdings Inc. | FY2026 Q3 · Calendar Q4 2026 | +13.4% | +11.0% | PDD’s Q3: Steady Revenue, Slight Income Growth Amid Heavy Investment |
| LOW Lowe's Companies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +7.6% | +1.1% | Lowe’s raises FY2026 sales outlook as Pro, digital and services demand support Q3 |
| TJX The TJX Companies, Inc. | FY2027 Q3 · Calendar Q4 2026 | 0.0% | +8.0% | TJX raises FY2027 outlook as comparable sales grow, costs pressure margins |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPFY2026 Q3 · November 16, 2026-3.0% EPS-2.5% move
Get the ORLY recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-07-30T20:11:07.646100+00:00
- FN2 earnings calendar · 2026-09-03T01:23:14.877038+00:00
- Polygon adjusted daily market bars · 2026-09-23T12:20:57.909137+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T12:20:57.906241+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.